In contrast, in squamous cell carcinoma, inhibition of EIF2S1 is compensated for by an alternative translation initiation factor, EIF2A, thereby sustaining the survival of squamous cell carcinoma despite the inhibition of EIF2S1 [27]. Here, EIF2A is linked to squamous cell carcinoma.